Johns Hopkins Bloomberg School of Public
Health researchers identified a new synthetic compound, called CDDO-Im, as effective in preventing the development of
cancers with a strong link to
inflammation, such as liver, colon, prostate and gastric cancers. In laboratory experiments, CDDO-Im had a 99
percent success rate in the reduction of pre-cancerous lesions. The compound stimulates the enzymes that remove toxic
substances from cells, increasing the resistance of cells to cancer-causing toxins. CDDO-Im is derived from oleanolic
acid, a naturally occurring substance found in many plants.Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
New compound protects liver from cancer cells
Johns Hopkins Bloomberg School of Public
Health researchers identified a new synthetic compound, called CDDO-Im, as effective in preventing the development of
cancers with a strong link to
inflammation, such as liver, colon, prostate and gastric cancers. In laboratory experiments, CDDO-Im had a 99
percent success rate in the reduction of pre-cancerous lesions. The compound stimulates the enzymes that remove toxic
substances from cells, increasing the resistance of cells to cancer-causing toxins. CDDO-Im is derived from oleanolic
acid, a naturally occurring substance found in many plants.
